COVID, Cancer Care, and Cancer Research - National Coalition for Cancer Survivorship Cancer Policy Roundtable
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
COVID, Cancer Care, and Cancer Research National Coalition for Cancer Survivorship Cancer Policy Roundtable Norman E. Sharpless, M.D. April 22, 2021 @NCIDirector @TheNCI
Today • 50th Anniversary of the National Cancer Act • Cancer Moonshot • NCI Appropriations & Paylines • COVID-19 Impacts and Activities • NCI Activities in Cancer Survivorship • Equity and Inclusion 2
“The President and I stand with you. This is the fight of our lives, and we will never stop working to end this disease. And together, I know that we're going to go farther than ever before.” Dr. Jill Biden Virtual Visit to NCI February 3, 2021 I’d love to be the President to preside over the end of cancer as we know it. These are the folks in the House and Senate who would love to preside over cancer —the end of cancer as we know it. President Joe Biden Bipartisan Meeting on Cancer, Oval Office March 3, 2021 3
Select Cancer Moonshot efforts in survivorship Initiative Grants / Projects Principal Investigator Improving the Management of A Randomized Trial of a Mobile Health and Nina S. Kadan-Lottick, symPtoms during and Social Media Physical Activity Intervention Jason A. Mendoza following Cancer Treatment Among Adolescent and Young Adult (IMPACT) Childhood Cancer Survivors Improving Outcomes for Self-Management to Optimize Survivorship Virginia Chih-Yi Sun Pediatric, Adolescent and Care and Outcomes in Lung and Colorectal Young Adult (AYA) Cancer Cancer Survivors Optimizing the Management The EPICS (Engaging Primary Care In Erin Elizabeth Hahn and Outcomes for Cancer Cancer Survivorship) Study: A Randomized Survivors Transitioning to Trial of Novel Models of Care for Cancer Follow-up Care Survivors Optimizing Functional Outcomes of Older Supriya G. Mohile, Michelle Survivors After Chemotherapy C. Janelsins, Karen M. Mustian 7
NCI Appropriations 21st Century Cures Act - orange FY 2015 – 2021 (in millions) Childhood Cancer Initiative - green $6,560 $7,000 $6,440 $5,965 $6,144 $195 $195 $50 $50 $6,000 $5,689 $400 $300 $6,195 $6,315 $300 $5,665 $5,744 $5,000 $5,389 $5,215 $4,950 $4,000 + $306M COVID-19 $3,000 serology (April 2020) $2,000 $1,000 $0 FY 2015 FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 8
NCI Paylines for FY 2021 GRANT TYPE PAYLINE R01 Grants for 15 by 25 Established and New 11th Percentile Investigators goal R01 Grants for Early- Stage Investigators (ESIs) 16th Percentile 15th percentile R21 Exploratory Grants 9th Percentile R01 payline Non-competing grants will be funded at 100%. by 2025 9
NCI COVID-19 activities F O U N D AT I O N A L CLINICAL & SUPPORT FOR CANCER SEROLOGY T R A N S L AT I O N A L RESEARCH AND CARE A M I D T H E PA N D E M I C SEROLOGY Serological Sciences NCI COVID-19 in Cancer Sero-protection Studies: Network (SeroNet) • Mount Sinai, University of Arizona Patients Study (NCCAPS) • NIH All of Us Flexibilities for grantees • 8 Centers of • NCI SEER + Health Verity Excellence Clinical trials adaptations COVID-19 Seroprevalence Studies Modeling to predict long-term • 13 Research Projects Hub (SeroHub) cancer outcomes • 4 Capacity Building Centers Antibody test performance evaluation, with FDA ADDITIONAL COVID-19 • FNL Serology Lab & Network Coordinating Standard reference serum RESEARCH Center • Excess Mortality Study Clinical trials for COVID-19 therapeutics • Digital Health • Tocilizumab Solutions (with NIBIB) • CD24Fc • ACTIV (trans-NIH) 10
NCI COVID-19 in Cancer Patients Study (NCCAPS) 900+ Special emphasis on minority, Enrolled patients will TRIAL SITES underserved and be followed ACTIVATED IN rural communities for 2 years 1051 50 Now open to pediatric patients Aims to enroll PATIENTS ENROLLED STATES 2,000 patients + DC, PUERTO Launched May 21 across 1,000 RICO, AND Conception to Launch in sites in U.S. CANADA 6 weeks As of April 19, 2021. 11
COVID-19 & Cancer time.com AUGUST 28, 2020 12
Impact of COVID-19 Pandemic on Cancer Screening in the US Colorectal Cancer Screening Lung Cancer Screening (Colonoscopy and FIT) (LDCT) Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute’s PROSPR Consortium. Gastroenterology, Volume 160, Issue 4, 999 - 1002 13
Impact of COVID-19 Pandemic on Cancer Screening in the US Cervical Cancer Screening Breast Cancer Screening (Pap Smear) (Mammography) Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute’s PROSPR Consortium. Gastroenterology, Volume 160, Issue 4, 999 - 1002 14
Centers on Telehealth Research for Cancer-Related Care – Goals: Leverage the P50 mechanism to: 1. Create national centers for advancing RFA cancer-related telehealth research in a CA-21-029 rapidly changing environment 2. Establish a robust evidence base for patient-centered, sustainable telehealth models of cancer care delivery 3. Foster the development, evaluation, and dissemination of evidence-based models of cancer-focused telehealth 15
Emily S. Tonorezos, MD, MPH Director Office of Cancer Survivorship Division of Cancer Control and Population Sciences 16
STAR Act Implementation Identifying best New survivorship New biobanking practices in research opportunities projects survivorship care • Improving Outcomes for • Several Children’s • Partnership with the Agency Pediatric, Adolescent and Oncology Group projects, for Healthcare Research and Young Adult Cancer including the Rare Tumor Quality (AHRQ) Survivors: 7 U01 awards Populations Biobank • 1st of 3 evidence reviews • Research to Reduce • Projects in collaboration with published in March 2021 Morbidity and Improve Care the Childhood Cancer focused on Disparities and for Pediatric, and Adolescent Survivor Study Barriers to Pediatric Cancer and Young Adult (AYA) Survivorship Care Cancer Survivors • Specimen collection efforts in • 2 reviews in progress, to be collaboration with the published later this year, Childhood Cancer Data focusing on models of care Initiative and transitions in care 17
4/23/21
NCI Equity and Inclusion Program EQUITY Chair Mark Alexander Montse Garcia- Donna Siegle Ned Sharpless Andrea Apolo Closas Dinah Singer COUNCIL Nelvis Castro Anne Lubenow Sanya Springfield Vice Chair Bob Croyle Ji Luo Paulette Gray WORKING GROUP 1 WORKING GROUP 2 WORKING GROUP 3 WORKING GROUP 4 WORKING GROUP 5 Enhancing Ensuring Diversity of Promoting an Systematic Tracking Communications Research to Thought and Inclusive and and Evaluation of and Outreach for Address Cancer Background in the Equitable Community Equity Activities Equity Activities Health Disparities Cancer Research at NCI Workforce CO-CHAIRS CO-CHAIRS CO-CHAIRS CO-CHAIRS CO-CHAIRS Jim Doroshow LeeAnn Bailey Shannon Bell Michelle Bennett Peter Garrett Worta McCaskill- Susan McCarthy Paige Green Doug Lowy Angela Jones Stevens Glenn Merlino Satish Gopal Anita Linde Tiffany Wallace 19
Discussion
You can also read